Deep learning models can help assess lung cancer diagnoses.

Published Date: 02 Mar 2023

A deep learning model called Sybil can predict future lung cancer risk based on a low-dose chest CT scan and identify people who are likely to benefit from regular treatment.

Read Full News

Latest News

Pharmacoepidemiology Faces AI, Data Challenges

AI, big data, and environmental exposures are reshaping pharmacoepidemiology, while experts warn that patients must play a bigger role in research.

Increasing Molecular Testing Compliance via Molecular Rounds

By launching weekly "molecular rounds," a VA oncology program raised lung cancer molecular testing compliance to 78% and prostate cancer to 51%.

Accelerated Pembrolizumab/Nivolumab Infusions: Safety Study

42 veterans, 60 accelerated infusions, one mild reaction: 10-minute pembrolizumab/nivolumab protocols saved 20 hours of chair time safely.

Expanding Close-to-Me Infusion Services

The Close-to-Me program was launched to bring infusion therapies closer to veterans, reducing travel burden and improving access for rural veterans.

Cognitive Screening in MS: The Digital Advantage

Dr Elizabeth Gromisch explores digital cognitive screening in multiple sclerosis, from its role in care to clinical integration and emerging options.

Reducing Infusion Wait Times at VA New Jersey

VA New Jersey slashed chemo infusion wait times 32% — from 164 to 106 minutes — through order templates, pre-visit bloodwork, and a fast-track room.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Latest News

AI, big data, and environmental exposures are reshaping pharmacoepidemiology, while experts warn that patients must play a bigger role in research.

By launching weekly "molecular rounds," a VA oncology program raised lung cancer molecular testing compliance to 78% and prostate cancer to 51%.

42 veterans, 60 accelerated infusions, one mild reaction: 10-minute pembrolizumab/nivolumab protocols saved 20 hours of chair time safely.

The Close-to-Me program was launched to bring infusion therapies closer to veterans, reducing travel burden and improving access for rural veterans.

Dr Elizabeth Gromisch explores digital cognitive screening in multiple sclerosis, from its role in care to clinical integration and emerging options.

VA New Jersey slashed chemo infusion wait times 32% — from 164 to 106 minutes — through order templates, pre-visit bloodwork, and a fast-track room.

News All Time

AI in Gastroenterology: Benefits vs Harms

AI applications are poised to become the mandated standard of practice in gastroenterology, and in some institutions already are.

Esophagitis Dissecans Superficialis in Woman With Dysphagia

A woman presents with progressive dysphagia and vomiting; endoscopy reveals extensive esophageal mucosal sloughing consistent with esophagitis dissecans superficialis.

AI in Medicine Reduces Burden, Not Judgment

AI in medicine isn’t about replacing clinical reasoning. It’s about freeing up physicians to do more of what only they can do.

Laughter Really Is The Best Medicine

The data on laughter are more serious than you’d expect. Dr Neil Skolnik breaks down the physiological benefits of humor.

New CRP Cutoff Can Flag High-Risk Ulcerative Colitis Cases

Lowering the CRP threshold helps identify hospitalized patients with ulcerative colitis at a risk for colectomy who would have been missed by the traditional criteria.

Gaps in Access to Maternity Care Tied to Labor Induction

Maternal residence in rural, lower-access counties is associated with an increased risk for labor induction at full term.

PPI Linked to Lower Gastric Cancer Mortality Risk

In contrast to prior research showing PPI may mask signs of gastric cancer and delay diagnosis, new research shows diagnosis was in fact earlier and mortality, lower.

IMpower030: Atezolizumab Misses Primary Endpoint in NSCLC

Perioperative atezolizumab nearly doubles median event-free survival in resectable non-small cell lung cancer, but the primary endpoint did not reach statistical significance.

Which Rx Is Best for ADHD Plus Stimulant Use Disorder?

Stimulant-based pharmacotherapies, especially high-dose mixed amphetamine salt, are associated with improved outcomes in adults with ADHD plus stimulant use disorder.

Teens Use AI for Emotional Support: What Doctors Should Know

Teens' AI use becomes problematic when a chatbot replaces a trusted adult or peer, according to psychiatrists.

Buridan’s Ass and the Limits of Medical Reasoning

Not every clinical dilemma has a rational answer, and pretending otherwise carries its own risks.

AI Tool Shows Promise for Lung Cancer Response Assessment

An AI algorithm accurately evaluates pathologic response after neoadjuvant chemoimmunotherapy in patients with NSCLC, showing moderate concordance with expert pathologist consensus across cohorts.

9/11-Related Cancers Still Emerging 25 Years Later

Cancer diagnoses among people exposed to the World Trade Center disaster continue to be reported 25 years after 9/11, highlighting the long latency of some WTC-related malignancies.

FDA OKs First Drug to Target Muscle Loss in SMA

Apitegromab is the first SMA therapy to directly target muscle loss and is approved as add-on treatment for patients aged 2 years and older receiving an SMN2-targeted therapy.

Admin Hurdles, Not Insurance, Block Bariatric Surgery Access

Secret shopper calls to bariatric programs in two US states find that administrative and scheduling barriers — not insurance — may limit access to initial appointments.

Acute Otitis Media: The Cost of a Common Childhood Infection

Dr. Pichichero discusses the financial and health costs of acute otitis media.

Recommended News For You

AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma

Regular physical activity before cancer diagnosis may lower progression and death risks

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Resection for Early Liver Cancer Tied to Improved Survival.

Medication Self-Injection Embraced by Breast Cancer Patients

Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.

Recommended Articles For You

Gut microbiota in curing cancer 

3D Molecular Tumor Mapping for Therapy Selection 

Platelet Dysfunction During Severe Systemic Inflammation: Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches 

The benefits of using magnesium sulfate during pregnancy  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Trump slashed US cancer research by 31 percent: Senate report

2.

Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

3.

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

4.

Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

5.

Living in a more pedestrian-friendly area may reduce the risk of cancer and obesity-related diseases.

1.

Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders

2.

Case Study: Personalized Medicine Based on Genetic Profiling in Oncology

3.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

4.

Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies

5.

Fibroma: Understanding the Causes, Symptoms, and Treatment Options

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part II

2.

How Advances in Cancer Research Are Improving Treatment Options

3.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

4.

Understanding Platelet Disorders

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot